- Credit Type: CME
- Credit Amount: 1.00
- Cost: Free
- Release: Feb 2, 2017
- Expires: Feb 1, 2020
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Kentucky Regional Extension Center (REC) University of Kentucky
Needs StatementThere are significant changes to Medicare and Medicaid physician payments tied to quality and value starting in January, 2017. This module was created to prepare healthcare providers for the changes under the Medicare Access and CHIP Reauthorization Act and Value-Based Payment.
Target AudiencePhysicians, Health Administrators, Nurses, ARNP's, PA's, Podiatrists, and Health IT Professionals
ObjectivesUpon completion of this activity, participants will be able to:
1. Review the changes in health care reporting and reimbursements brought about by MACRA legislation
2. Describe what is needed to prepare for 2017 reporting including tips and tricks for MU and PQRS
3. Discuss how to organize your practice for MU, PQRS, and MACRA success
4. Cite the top HIPAA threats and success strategies for practices
5. Identify what is needed to prepare for practice transformation
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
- Practice-based learning and improvement
- Systems-based practice
Faculty DisclosureThe speaker has no relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.